Optiver Holding Portfolio holdings
Optiver Holding B.V., founded in 1986 by Johann Kaemingk, Ruud Vlek, and Chris Oomen in Amsterdam, Netherlands, is a leading global proprietary trading firm and market maker specializing in options, derivatives, equities, ETFs, bonds, and foreign exchange. Starting as an options market maker on the European Options Exchange (now Euronext), Optiver has grown into a tech-driven powerhouse with over 2,000 employees across offices in Chicago, Sydney, London, Singapore, and beyond, trading on more than 50 exchanges worldwide. Known for its advanced algorithms and low-latency systems, the firm provides liquidity and competitive pricing, emphasizing market efficiency and stability, though it faced a $14 million fine in 2012 for illegal "banging the close" tactics in U.S. oil futures. Privately owned and led by CEO Rob Defares, Optiver blends a collaborative culture with cutting-edge technology, making it a significant player in the global financial ecosystem.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$335M |
| 2 |
Apple
AAPL
|
+$179M |
| 3 |
Microsoft
MSFT
|
+$169M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$127M |
| 5 |
Amazon
AMZN
|
+$68M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$201M |
| 2 |
Tesla
TSLA
|
+$153M |
| 3 |
Advanced Micro Devices
AMD
|
+$140M |
| 4 |
NVIDIA
NVDA
|
+$63M |
| 5 |
ASML
ASML
|
+$50.4M |
Sector Composition
| 1 | Technology | 37.16% |
| 2 | Communication Services | 15.61% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Energy | 5.26% |
| 5 | Healthcare | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Sangamo Therapeutics
SGMO
$157M
| $1.73K | ﹤0.01% |
3,200
| – | – |
|
1052
Ventyx Biosciences
VTYX
$170M
| $1.73K | ﹤0.01% |
806
| – | – |
|
1053
Phillips 66
PSX
$53.5B
| $1.67K | ﹤0.01% |
+14
| New | +$1.67K |
|
1054
KeyCorp
KEY
$21B
| $1.64K | ﹤0.01% |
+94
| New | +$1.64K |
|
1055
Krispy Kreme
DNUT
$531M
| $1.59K | ﹤0.01% |
547
-1
| -0.2% | -$3 |
|
1056
RLJ Lodging Trust
RLJ
$1.16B
| $1.57K | ﹤0.01% |
216
-440
| -67% | -$3.2K |
|
1057
Marqeta
MQ
$2.73B
| $1.56K | ﹤0.01% |
+267
| New | +$1.56K |
|
1058
Frontier Group Holdings
ULCC
$1.16B
| $1.55K | ﹤0.01% |
426
| – | – |
|
1059
Zillow
ZG
$21B
| $1.51K | ﹤0.01% |
+22
| New | +$1.51K |
|
1060
B&G Foods
BGS
$366M
| $1.45K | ﹤0.01% |
343
| – | – |
|
1061
Ginkgo Bioworks
DNA
$637M
| $1.43K | ﹤0.01% |
127
| – | – |
|
1062
Anywhere Real Estate
HOUS
$729M
| $1.41K | ﹤0.01% |
390
| – | – |
|
1063
Caribou Biosciences
CRBU
$169M
| $1.39K | ﹤0.01% |
1,104
| – | – |
|
1064
Under Armour Class C
UA
$2.09B
| $1.38K | ﹤0.01% |
213
-116
| -35% | -$753 |
|
|
EVRI
1065
DELISTED
Everi Holdings
EVRI
| $1.37K | ﹤0.01% |
+96
| New | +$1.37K |
|
1066
Designer Brands
DBI
$215M
| $1.34K | ﹤0.01% |
561
| – | – |
|
1067
Sally Beauty Holdings
SBH
$1.45B
| $1.33K | ﹤0.01% |
144
| – | – |
|
1068
Peabody Energy
BTU
$2.25B
| $1.33K | ﹤0.01% |
99
-307
| -76% | -$4.12K |
|
|
EQC
1069
DELISTED
Equity Commonwealth
EQC
| $1.3K | ﹤0.01% |
823
| – | – |
|
1070
Fate Therapeutics
FATE
$111M
| $1.26K | ﹤0.01% |
1,129
+2
| +0.2% | +$2 |
|
1071
Allogene Therapeutics
ALLO
$253M
| $1.25K | ﹤0.01% |
1,108
| – | – |
|
1072
Bank of Montreal
BMO
$90.9B
| $1.22K | ﹤0.01% |
+11
| New | +$1.22K |
|
1073
ImmunityBio
IBRX
$2.43B
| $1.2K | ﹤0.01% |
+454
| New | +$1.2K |
|
1074
VF Corp
VFC
$5.95B
| $1.18K | ﹤0.01% |
100
+95
| +1,900% | +$1.12K |
|
1075
Lear
LEA
$5.91B
| $1.14K | ﹤0.01% |
12
-93
| -89% | -$8.84K |
|